38th Annual JP Morgan Healthcare Conference Recap & 2020 Outlook

January 22, 2020 4:00 PM - 6:00 PM

MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139

Add to Calendar 1/22/2020 4:00:00 PM 1/22/2020 6:00:00 PM 38th Annual JP Morgan Healthcare Conference Recap & 2020 Outlook

The annual JP Morgan Healthcare Conference in San Francisco is one of the largest and most informative healthcare investment symposiums in the industry. It brings together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Each year hundreds of companies, both public and private, deliver presentations to over 4,000 investors. In addition, thousands in biotech descend upon San Francisco to network, attend meetings and gain an inside view even if they can’t secure an official conference invite. If you can’t make it to the conference, or if your role does not require you to attend the JP Morgan conference, join us for a recap of it and hear ideas about the deals landscape for 2020 from a select group of conference insiders.

 MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Vice President/Head, Business Development, Sage Therapeutics
Ravneesh Sachdev is Vice President/Head, Business Development at Sage Therapeutics based in Cambridge. Sage is a biopharmaceutical company committed to discovering, developing and delivering novel medicines to transform the lives of patients with life-altering disorders of the central nervous system, including Zulresso™, the first FDA-approved drug specifically for post-partum depression. Ravneesh evaluates and transacts on partnerships in order to inorganically grow Sage’s business. Over the past 15+ years of his business development career, Ravneesh has contributed to, as well as, led the execution of more than 20 partnerships during his tenure at several other companies, namely Pfizer, Onyx Pharmaceuticals (now part of Amgen), UCB Pharma, Acorda Therapeutics and Bioverativ (now part of Sanofi). Ravneesh earned his Bachelor’s degree in Molecular Neuroscience from Claremont McKenna College, his Professional Science Masters degree from the Keck Graduate Institute and his MBA from Yale University School of Management.